China Biotech Holdings Ltd (1672886) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2018

China Biotech Holdings Ltd

CIK: 1672886

View differences made from one quarter to another to evaluate China Biotech Holdings Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by China Biotech Holdings Ltd.


Assess how China Biotech Holdings Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

China Biotech Holdings Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

China Biotech Holdings Ltd provided additional information to their SEC Filing as exhibits

CIK: 1672886
Form Type: 10-Q Quarterly Report
Accession Number: 0001079973-18-000587
Submitted to the SEC: Thu Oct 25 2018 5:30:30 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Saturday, June 30, 2018
Industry: Blank Checks

External Resources:

Bookmark the Permalink: